Bill Text: FL S1260 | 2010 | Regular Session | Introduced
Bill Title: Controlled Substances [SPSC]
Spectrum: Partisan Bill (Republican 2-0)
Status: (Failed) 2010-04-30 - Died in Committee on Criminal and Civil Justice Appropriations [S1260 Detail]
Download: Florida-2010-S1260-Introduced.html
Florida Senate - 2010 SB 1260 By Senator Fasano 11-00641-10 20101260__ 1 A bill to be entitled 2 An act relating to controlled substances; amending s. 3 893.03, F.S.; revising the list of controlled 4 substances in Schedules I, II, III, IV, and V; 5 providing that the salts, isomers, or salts of isomers 6 are included within certain substances listed in 7 Schedule III; providing an effective date. 8 9 Be It Enacted by the Legislature of the State of Florida: 10 11 Section 1. Paragraph (c) of subsection (1), paragraphs (a) 12 and (b) of subsection (2), paragraph (a) of subsection (3), 13 subsection (4), and paragraph (b) of subsection (5) of section 14 893.03, Florida Statutes, are amended to read: 15 893.03 Standards and schedules.—The substances enumerated 16 in this section are controlled by this chapter. The controlled 17 substances listed or to be listed in Schedules I, II, III, IV, 18 and V are included by whatever official, common, usual, 19 chemical, or trade name designated. The provisions of this 20 section shall not be construed to include within any of the 21 schedules contained in this section any excluded drugs listed 22 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded 23 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical 24 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted 25 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt 26 Anabolic Steroid Products.” 27 (1) SCHEDULE I.—A substance in Schedule I has a high 28 potential for abuse and has no currently accepted medical use in 29 treatment in the United States and in its use under medical 30 supervision does not meet accepted safety standards. The 31 following substances are controlled in Schedule I: 32 (c) Unless specifically excepted or unless listed in 33 another schedule, any material, compound, mixture, or 34 preparation which contains any quantity of the following 35 hallucinogenic substances or which contains any of their salts, 36 isomers, and salts of isomers, whenever the existence of such 37 salts, isomers, and salts of isomers is possible within the 38 specific chemical designation: 39 1. Alpha-ethyltryptamine. 40 2. 2-Amino-4-methyl-5-phenyl-2-oxazoline (4 41 methylaminorex). 42 3. 2-Amino-5-phenyl-2-oxazoline (Aminorex). 43 4. 4-Bromo-2,5-dimethoxyamphetamine. 44 5. 4-Bromo-2, 5-dimethoxyphenethylamine. 45 6. Bufotenine. 46 7. Cannabis. 47 8. Cathinone. 48 9. Diethyltryptamine. 49 10. 2,5-Dimethoxyamphetamine. 50 11. 2,5-Dimethoxy-4-ethylamphetamine (DOET). 51 12. Dimethyltryptamine. 52 13. N-Ethyl-1-phenylcyclohexylamine (PCE) (Ethylamine 53 analog of phencyclidine). 54 14. N-Ethyl-3-piperidyl benzilate. 55 15. N-ethylamphetamine. 56 16. Fenethylline. 57 17. N-Hydroxy-3,4-methylenedioxyamphetamine. 58 18. Ibogaine. 59 19. Lysergic acid diethylamide (LSD). 60 20. Mescaline. 61 21. Methcathinone. 62 22. 5-Methoxy-3,4-methylenedioxyamphetamine. 63 23. 4-methoxyamphetamine. 64 24. 4-methoxymethamphetamine. 65 25. 4-Methyl-2,5-dimethoxyamphetamine. 66 26. 3,4-Methylenedioxy-N-ethylamphetamine. 67 27. 3,4-Methylenedioxyamphetamine. 68 28. N-Methyl-3-piperidyl benzilate. 69 29. N,N-dimethylamphetamine. 70 30. Parahexyl. 71 31. Peyote. 72 32. N-(1-Phenylcyclohexyl)-pyrrolidine (PCPY) (Pyrrolidine 73 analog of phencyclidine). 74 33. Psilocybin. 75 34. Psilocyn. 76 35. Salvia divinorum, except for any drug product approved 77 by the United States Food and Drug Administration which contains 78 Salvia divinorum or its isomers, esters, ethers, salts, and 79 salts of isomers, esters, and ethers, whenever the existence of 80 such isomers, esters, ethers, and salts is possible within the 81 specific chemical designation. 82 36. Salvinorin A, except for any drug product approved by 83 the United States Food and Drug Administration which contains 84 Salvinorin A or its isomers, esters, ethers, salts, and salts of 85 isomers, esters, and ethers, whenever the existence of such 86 isomers, esters, ethers, and salts is possible within the 87 specific chemical designation. 88 37. Tetrahydrocannabinols. 89 38. 1-[1-(2-Thienyl)-cyclohexyl]-piperidine (TCP) 90 (Thiophene analog of phencyclidine). 91 39. 3,4,5-Trimethoxyamphetamine. 92 40. Alpha-methyltryptamine. 93 41. 1-(1-Phenylcyclohexyl) pyrrolidine. 94 42. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine. 95 43. 5-Methoxy-N, N-diisopropyltryptamine. 96 44. N-Benzylpiperazine. 97 (2) SCHEDULE II.—A substance in Schedule II has a high 98 potential for abuse and has a currently accepted but severely 99 restricted medical use in treatment in the United States, and 100 abuse of the substance may lead to severe psychological or 101 physical dependence. The following substances are controlled in 102 Schedule II: 103 (a) Unless specifically excepted or unless listed in 104 another schedule, any of the following substances, whether 105 produced directly or indirectly by extraction from substances of 106 vegetable origin or independently by means of chemical 107 synthesis: 108 1. Opium and any salt, compound, derivative, or preparation 109 of opium, except nalmefene or isoquinoline alkaloids of opium, 110 including, but not limited to the following: 111 a. Raw opium. 112 b. Opium extracts. 113 c. Opium fluid extracts. 114 d. Powdered opium. 115 e. Granulated opium. 116 f. Tincture of opium. 117 g. Codeine. 118 h. Ethylmorphine. 119 i. Etorphine hydrochloride. 120 j. Hydrocodone. 121 k. Hydromorphone. 122 l. Levo-alphacetylmethadol (also known as levo-alpha 123 acetylmethadol, levomethadyl acetate, or LAAM). 124 m. Metopon (methyldihydromorphinone). 125 n. Morphine. 126 o. Oxycodone. 127 p. Oxymorphone. 128 q. Thebaine. 129 r. Dihydroetorphine. 130 2. Any salt, compound, derivative, or preparation of a 131 substance which is chemically equivalent to or identical with 132 any of the substances referred to in subparagraph 1., except 133 that these substances shall not include the isoquinoline 134 alkaloids of opium. 135 3. Any part of the plant of the species Papaver somniferum, 136 L. 137 4. Cocaine or ecgonine, including any of their 138 stereoisomers, and any salt, compound, derivative, or 139 preparation of cocaine or ecgonine. 140 (b) Unless specifically excepted or unless listed in 141 another schedule, any of the following substances, including 142 their isomers, esters, ethers, salts, and salts of isomers, 143 esters, and ethers, whenever the existence of such isomers, 144 esters, ethers, and salts is possible within the specific 145 chemical designation: 146 1. Alfentanil. 147 2. Alphaprodine. 148 3. Anileridine. 149 4. Bezitramide. 150 5. Bulk propoxyphene (nondosage forms). 151 6. Carfentanil. 152 7. Dihydrocodeine. 153 8. Diphenoxylate. 154 9. Fentanyl. 155 10. Isomethadone. 156 11. Levomethorphan. 157 12. Levorphanol. 158 13. Metazocine. 159 14. Methadone. 160 15. Methadone-Intermediate,4-cyano-2- 161 dimethylamino-4,4-diphenylbutane. 162 16. Moramide-Intermediate,2-methyl- 163 3-morpholoino-1,1-diphenylpropane-carboxylic acid. 164 17. Nabilone. 165 18. Pethidine (meperidine). 166 19. Pethidine-Intermediate-A,4-cyano-1- 167 methyl-4-phenylpiperidine. 168 20. Pethidine-Intermediate-B,ethyl-4- 169 phenylpiperidine-4-carboxylate. 170 21. Pethidine-Intermediate-C,1-methyl-4- phenylpiperidine 171 4-carboxylic acid. 172 22. Phenazocine. 173 23. Phencyclidine. 174 24. 1-Phenylcyclohexylamine. 175 25. Piminodine. 176 26. 1-Piperidinocyclohexanecarbonitrile. 177 27. Racemethorphan. 178 28. Racemorphan. 179 29. Sufentanil. 180 30. Lisdexamfetamine. 181 31. Remifentanil. 182 (3) SCHEDULE III.—A substance in Schedule III has a 183 potential for abuse less than the substances contained in 184 Schedules I and II and has a currently accepted medical use in 185 treatment in the United States, and abuse of the substance may 186 lead to moderate or low physical dependence or high 187 psychological dependence or, in the case of anabolic steroids, 188 may lead to physical damage. The following substances are 189 controlled in Schedule III: 190 (a) Unless specifically excepted or unless listed in 191 another schedule, any material, compound, mixture, or 192 preparation which contains any quantity of the following 193 substances having a depressant or stimulant effect on the 194 nervous system, including its salts, isomers, and salts of 195 isomers whenever the existence of such salts, isomers, or salts 196 of isomers is possible within the specific chemical designation: 197 1. Any substance which contains any quantity of a 198 derivative of barbituric acid, including thiobarbituric acid, or 199 any salt of a derivative of barbituric acid or thiobarbituric 200 acid, including, but not limited to, butabarbital and 201 butalbital. 202 2. Benzphetamine. 203 3. Chlorhexadol. 204 4. Chlorphentermine. 205 5. Clortermine. 206 6. Lysergic acid. 207 7. Lysergic acid amide. 208 8. Methyprylon. 209 9. Phendimetrazine. 210 10. Sulfondiethylmethane. 211 11. Sulfonethylmethane. 212 12. Sulfonmethane. 213 13. Tiletamine and zolazepamor any salt thereof. 214 14. Embutramide. 215 (4) SCHEDULE IV.—A substance in Schedule IV has a low 216 potential for abuse relative to the substances in Schedule III 217 and has a currently accepted medical use in treatment in the 218 United States, and abuse of the substance may lead to limited 219 physical or psychological dependence relative to the substances 220 in Schedule III. Unless specifically excepted or unless listed 221 in another schedule, any material, compound, mixture, or 222 preparation which contains any quantity of the following 223 substances, including its salts, isomers, and salts of isomers 224 whenever the existence of such salts, isomers, and salts of 225 isomers is possible within the specific chemical designation, 226 are controlled in Schedule IV: 227 (a) Alprazolam. 228 (b) Barbital. 229 (c) Bromazepam. 230 (d) Camazepam. 231 (e) Cathine. 232 (f) Chloral betaine. 233 (g) Chloral hydrate. 234 (h) Chlordiazepoxide. 235 (i) Clobazam. 236 (j) Clonazepam. 237 (k) Clorazepate. 238 (l) Clotiazepam. 239 (m) Cloxazolam. 240 (n) Delorazepam. 241 (o) Propoxyphene (dosage forms). 242 (p) Diazepam. 243 (q) Diethylpropion. 244 (r) Estazolam. 245 (s) Ethchlorvynol. 246 (t) Ethinamate. 247 (u) Ethyl loflazepate. 248 (v) Fencamfamin. 249 (w) Fenfluramine. 250 (x) Fenproporex. 251 (y) Fludiazepam. 252 (z) Flurazepam. 253 (aa) Halazepam. 254 (bb) Haloxazolam. 255 (cc) Ketazolam. 256 (dd) Loprazolam. 257 (ee) Lorazepam. 258 (ff) Lormetazepam. 259 (gg) Mazindol. 260 (hh) Mebutamate. 261 (ii) Medazepam. 262 (jj) Mefenorex. 263 (kk) Meprobamate. 264 (ll) Methohexital. 265 (mm) Methylphenobarbital. 266 (nn) Midazolam. 267 (oo) Nimetazepam. 268 (pp) Nitrazepam. 269 (qq) Nordiazepam. 270 (rr) Oxazepam. 271 (ss) Oxazolam. 272 (tt) Paraldehyde. 273 (uu) Pemoline. 274 (vv) Pentazocine. 275 (ww) Phenobarbital. 276 (xx) Phentermine. 277 (yy) Pinazepam. 278 (zz) Pipradrol. 279 (aaa) Prazepam. 280 (bbb) Propylhexedrine, excluding any patent or proprietary 281 preparation containing propylhexedrine, unless otherwise 282 provided by federal law. 283 (ccc) Quazepam. 284 (ddd) Tetrazepam. 285 (eee) SPA[(-)-1 dimethylamino-1, 2 diphenylethane]. 286 (fff) Temazepam. 287 (ggg) Triazolam. 288 (hhh) Not more than 1 milligram of difenoxin and not less 289 than 25 micrograms of atropine sulfate per dosage unit. 290 (iii) Butorphanol tartrate. 291 (jjj) Carisoprodol. 292 (kkk) Zopiclone. 293 (lll) Zaleplon. 294 (mmm) Zolpidem. 295 (nnn) Modafinil. 296 (ooo) Petrichloral. 297 (ppp) Sibutramine. 298 (qqq) Dichloralphenazone. 299 (5) SCHEDULE V.—A substance, compound, mixture, or 300 preparation of a substance in Schedule V has a low potential for 301 abuse relative to the substances in Schedule IV and has a 302 currently accepted medical use in treatment in the United 303 States, and abuse of such compound, mixture, or preparation may 304 lead to limited physical or psychological dependence relative to 305 the substances in Schedule IV. 306 (b) Narcotic drugs. Unless specifically excepted or unless 307 listed in another schedule, any material, compound, mixture, or 308 preparation containing any of the following narcotic drugs and 309 their salts: 310 1. Buprenorphine. 311 2. Pregabalin. 312 3. Not more than 0.5 milligrams of difenoxin and not less 313 than 25 micrograms of atrophine sulfate per dosage unit. 314 Section 2. This act shall take effect July 1, 2010.
